LiveRamp Holdings Files Q3 2025 10-Q
Ticker: RAMP · Form: 10-Q · Filed: Feb 5, 2025 · CIK: 733269
| Field | Detail |
|---|---|
| Company | Liveramp Holdings, Inc. (RAMP) |
| Form Type | 10-Q |
| Filed Date | Feb 5, 2025 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
Related Tickers: RAMP
TL;DR
LiveRamp (RAMP) filed its Q3 2025 10-Q. Check financials.
AI Summary
LiveRamp Holdings, Inc. filed its 10-Q for the period ending December 31, 2024. The company, formerly known as Acxiom Holdings, Inc., reported financial results for its third fiscal quarter of 2025. Key financial data and operational details are provided in this filing.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for LiveRamp Holdings, Inc., crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial information.
Key Players & Entities
- LiveRamp Holdings, Inc. (company) — Filer
- Acxiom Holdings, Inc. (company) — Former company name
- 20241231 (date) — Reporting period end date
- 20250205 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The 10-Q filing is for the period ended December 31, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on February 5, 2025.
What was LiveRamp Holdings, Inc. formerly known as?
LiveRamp Holdings, Inc. was formerly known as Acxiom Holdings, Inc.
What is the fiscal year end for LiveRamp Holdings, Inc.?
The fiscal year end for LiveRamp Holdings, Inc. is March 31.
What is the Standard Industrial Classification code for LiveRamp Holdings, Inc.?
The Standard Industrial Classification code is 7374, for SERVICES-COMPUTER PROCESSING & DATA PREPARATION.
Filing Stats: 4,543 words · 18 min read · ~15 pages · Grade level 19.6 · Accepted 2025-02-05 17:04:48
Filing Documents
- ramp-20241231.htm (10-Q) — 1349KB
- a2025q3ex311ceosection302c.htm (EX-31.1) — 11KB
- a2025q3ex312cfosection302c.htm (EX-31.2) — 11KB
- a2025q3ex321ceosection1350.htm (EX-32.1) — 5KB
- a2025q3ex322cfosection1350.htm (EX-32.2) — 5KB
- ramp-20241231_g1.jpg (GRAPHIC) — 136KB
- 0000733269-25-000015.txt ( ) — 8527KB
- ramp-20241231.xsd (EX-101.SCH) — 62KB
- ramp-20241231_cal.xml (EX-101.CAL) — 106KB
- ramp-20241231_def.xml (EX-101.DEF) — 248KB
- ramp-20241231_lab.xml (EX-101.LAB) — 726KB
- ramp-20241231_pre.xml (EX-101.PRE) — 522KB
- ramp-20241231_htm.xml (XML) — 1230KB
Forward-looking Statements
Forward-looking Statements 3
Financial Information
Part I. Financial Information Item 1.
Financial Statements
Financial Statements 6 Condensed Consolidated Balance Sheets as of December 31, 2024 (Unaudited) and March 31, 2024 6 Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2024 and 2023 (Unaudited) 7 Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended December 31, 2024 and 2023 (Unaudited) 8 Condensed Consolidated Statements of Equity for the three and nine months ended December 31, 2024 (Unaudited) 9 Condensed Consolidated Statements of Equity for the three and nine months ended December 31, 2023 (Unaudited) 10 Condensed Consolidated Statements of Cash Flows for the nine months ended December 31, 2024 and 2023 (Unaudited) 11 Notes to Condensed Consolidated Financial Statements 13 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 29 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 44 Item 4.
Controls and Procedures
Controls and Procedures 44
Other Information
Part II. Other Information Item 1.
Legal Proceedings
Legal Proceedings 45 Item 1A.
Risk Factors
Risk Factors 45 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 46 Item 3. Defaults Upon Senior Securities 47 Item 4. Mine Safety Disclosures 47 Item 5. Other Information 47 Item 6. Exhibits 48 Signature 49 2
Forward-looking Statements
Forward-looking Statements This Quarterly Report on Form 10-Q, including, without limitation, the items set forth beginning in the Management's Discussion and Analysis of Financial Condition and Results of Operations, contains and may incorporate by reference certain statements that may be deemed to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended (the "PSLRA"), and that are intended to enjoy the protection of the safe harbor for forward-looking statements provided by the PSLRA. These statements, which are not statements of historical fact, may contain estimates, assumptions, projections and/or expectations regarding the Company's financial position, results of operations, market position, product development, growth opportunities, economic conditions, and other similar forecasts and statements of expectation. Forward-looking statements are often identified by words or phrases such as "anticipate," "estimate," "plan," "expect," "believe," "intend," "foresee," or the negative of these terms or other similar variations thereof. These forward-looking statements are not guarantees of future performance and are subject to a number of factors and uncertainties that could cause the Company's actual results and experiences to differ materially from the anticipated results and expectations expressed in the forward-looking statements.
Forward-looking statements may include but are not limited to the following
Forward-looking statements may include but are not limited to the following: management's expectations about the macro economy and trends within the consumer or business information industries, including the use of data and consumer expectations related thereto; our expectations regarding laws, regulations and industry practices governing the collection and use of personal data; our expectations regarding the potential impact of public health crises, similar to the COVID-19 pandemic, on our business, operations, and the markets in which we and our partners and customers operate; our expectations regarding the impact of tax-related legislation on our tax position; our estimates, assumptions, projections and/or expectations regarding the Company's annualized future cost savings and expenses associated with our global workforce strategy and real estate footprint reduction; Among the factors that may cause actual results and expectations to differ from anticipated results and expectations expressed in such forward-looking statements are the following: the risk factors described in Part I,
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (Dollars in thousands) December 31, March 31, 2024 2024 ASSETS (unaudited) Current assets: Cash and cash equivalents $ 376,772 $ 336,867 Restricted cash 593 2,604 Short-term investments 7,500 32,045 Trade accounts receivable, net 210,565 190,313 Refundable income taxes, net 6,630 8,521 Other current assets 41,747 31,682 Total current assets 643,807 602,032 Property and equipment, net of accumulated depreciation and amortization 6,659 8,181 Intangible assets, net 23,302 34,583 Goodwill 501,559 501,756 Deferred commissions, net 44,497 48,143 Other assets, net 33,389 36,748 $ 1,253,213 $ 1,231,443 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Trade accounts payable $ 105,334 $ 81,202 Accrued payroll and related expenses 35,639 61,575 Other accrued expenses 45,856 42,857 Deferred revenue 44,795 30,942 Total current liabilities 231,624 216,576 Other liabilities 63,882 65,732 Commitments and contingencies (Note 14) Stockholders' equity: Preferred stock — — Common stock 15,853 15,594 Additional paid-in capital 2,022,227 1,933,776 Retained earnings 1,319,625 1,314,172 Accumulated other comprehensive income 3,493 3,964 Treasury stock, at cost ( 2,403,491 ) ( 2,318,371 ) Total stockholders' equity 957,707 949,135 $ 1,253,213 $ 1,231,443 See accompanying notes to condensed consolidated financial statements. 6 LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (Dollars in thousands, except per share amounts) For the three months ended For the nine months ended December 31, December 31, 2024 2023 2024 2023 Revenues $ 195,412 $ 173,869 $ 556,856 $ 487,809 Cost of revenue 54,998 44,934 157,981 131,767 Gross profit 140,414 128,935 398,875 356,042 Operating expenses Research and development 42,735 37,788 130,742 106,040 Sales and marketing 50,863 46,203